发布时间：2017-07-19 11:13:48

TA-02产品描述：TA-02 is a p38 MAPK inhibitor with IC50 of 20 nM.IC50 value: 20 nMTarget: p38TA-02 is a novel compound with similar cardiogenic properties asSB203580 and SB202190. TA-02 especially inhibits TGFBR-2.公司介绍：MedChemExpress(MCE)专注于各种抑制剂、激动剂、API及化合物库，总部位于美.........【阅读全文】

发布时间：2017-07-19 11:13:01

TA-01产品描述：TA-01 potently inhibits CK1ε, CK1δ,and p38α (IC50values are 6.4, 6.8, and 6.7 nM respectively).IC50 value: 6.4/6.8/6.7 nMTarget: CK1ε/ CK1δ/p38α MAPKin vitro: TA-01 inhibitors inhibit cardiac development when applied at 5 μM. TA-01 shows an almost complete inhibition of card.........【阅读全文】

发布时间：2017-07-19 11:12:28

WEHI-345 analog产品描述：WEHI-345 (analog) is a Src inhibitor, extracted from patent WO/2012003544A1, compound example 71.Target:SrcWEHI-345 (analog) is a protein kinase inhibitor. A family of proto-oncogenic TPKs referred to herein as SFKs (Src family kinases) have provided researchers with a bet.........【阅读全文】

发布时间：2017-07-19 11:11:54

KNK437产品描述：KNK437, dose-dependently inhibited the acquisition of thermotolerance and the induction of various HSPs including HSP105, HSP70, and HSP40 in COLO 320DM (human colon carcinoma) cells. It also inhibit mRNA levels with IC 50: 17 umol/L.[1] This compound also inhibited the acquisition .........【阅读全文】

发布时间：2017-07-19 11:08:17

SCH 563705产品描述：SCH 563705 is a potent dual CXCR2(IC50= 1.3 nM)/CXCR1(IC50= 7.3 nM) antagonist.IC50 value: 7.3 nM (CXCR1); 1.3 nM (CXCR2) [1]Target: CXCR1; CXCR2in vitro: SCH 563705 has emerged as the most potent CXCR2–CXCR1 dual antagonist to date. It has been evaluated further in a wide ra.........【阅读全文】